These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11386281)

  • 1. A pneumococcal conjugate vaccine and acute otitis media.
    Sauder KL
    N Engl J Med; 2001 May; 344(22):1720. PubMed ID: 11386281
    [No Abstract]   [Full Text] [Related]  

  • 2. A pneumococcal conjugate vaccine and acute otitis media.
    Lavin A
    N Engl J Med; 2001 May; 344(22):1719; author reply 1720. PubMed ID: 11386278
    [No Abstract]   [Full Text] [Related]  

  • 3. A pneumococcal conjugate vaccine and acute otitis media.
    Cantekin EI
    N Engl J Med; 2001 May; 344(22):1719-20. PubMed ID: 11386277
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
    Eskola J; Kilpi T; Palmu A; Jokinen J; Haapakoski J; Herva E; Takala A; Käyhty H; Karma P; Kohberger R; Siber G; Mäkelä PH;
    N Engl J Med; 2001 Feb; 344(6):403-9. PubMed ID: 11172176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pneumococcal conjugate vaccine and acute otitis media.
    Ofran Y; Ofran A
    N Engl J Med; 2001 May; 344(22):1719; author reply 1720. PubMed ID: 11386279
    [No Abstract]   [Full Text] [Related]  

  • 6. A pneumococcal conjugate vaccine and acute otitis media.
    Damoiseaux RA
    N Engl J Med; 2001 May; 344(22):1719; author reply 1720. PubMed ID: 11386280
    [No Abstract]   [Full Text] [Related]  

  • 7. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pain in the ear: what has the 7-valent conjugated pneumococcal vaccine done to reduce the incidence of acute otitis media?
    Regelmann WE
    Clin Infect Dis; 2005 Jun; 40(12):1745-7. PubMed ID: 15909261
    [No Abstract]   [Full Text] [Related]  

  • 9. Brief review of the clinical effectiveness of PREVENAR against otitis media.
    Fletcher MA; Fritzell B
    Vaccine; 2007 Mar; 25(13):2507-12. PubMed ID: 17011085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of the heptavalent pneumococcal vaccine against meningitis, pneumonia and acute otitis media in pediatric age. Theoretical coverage offered by the heptavalent conjugate vaccine in Italy].
    Principi N; Esposito S
    Ann Ig; 2002; 14(6 Suppl 7):21-30. PubMed ID: 12638361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
    Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
    Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
    Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
    Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumonia vaccine.
    Malinoski FJ; Laufer DS
    J Fam Pract; 2001 Oct; 50(10):902. PubMed ID: 11674899
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.
    Barnett ED; Pelton SI; Cabral HJ; Eavey RD; Allen C; Cunningham MJ; McNamara ER; Klein JO
    Clin Infect Dis; 1999 Jul; 29(1):191-2. PubMed ID: 10433584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.
    Dagan R; Givon-Lavi N; Shkolnik L; Yagupsky P; Fraser D
    J Infect Dis; 2000 Apr; 181(4):1322-9. PubMed ID: 10753730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
    Toltzis P; Jacobs MR
    Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pneumococcal vaccination on quality of life in children with recurrent acute otitis media: a randomized, controlled trial.
    Brouwer CN; Maillé AR; Rovers MM; Veenhoven RH; Grobbee DE; Sanders EA; Schilder AG
    Pediatrics; 2005 Feb; 115(2):273-9. PubMed ID: 15687432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.